Organ Transplantation System Modernization
UNOS may no longer retain sole control of the organ transplantation network.
Editing the Human Genome
Scholars assess global regulatory practices concerning human genome editing.
Challenging Drug Patents to Lower Prices
The FTC cracks down on improperly listed drug patents, challenging over 100 patent listings.
Lessons Learned From COVID-19
The COVID-19 response illustrates steps officials should take to ensure the effectiveness of vaccine mandates.
The Future of Technology in Health Care
Scholars discuss the need for federal regulations to combat risks associated with technology in health care.
SCOTUS Must Not Look Away as Pregnant Patients Suffer
The Supreme Court must maintain pregnant people’s right to receive emergency medical care—including abortion.
A New Era of Psychedelic Medicine in Australia
Australia implements a new framework for regulating the medicinal use of psychedelic substances such as MDMA and psilocybin.
It Is High Time the U.K. Changes Psychedelics Laws
The government should lower regulatory hurdles impeding psilocybin assisted psychotherapy research.
Why We Need To Talk About Psychedelic Dispensaries
Dispensaries could fill the regulatory void for psychedelics and promote public health.
Are Psychedelics Safe Enough for Recreational Use?
Policymakers should account for the relatively low risks of psychedelics use when deciding how to regulate them.
A Roadmap to Reimbursement for Psychedelics
Insurance reimbursement for psychedelic therapy is integral to treatment accessibility.
Branching Regulatory Paths and Dead Ends in Psychedelics
The convergence of current psychedelics regulatory pathways may bring benefits and new challenges.